tiprankstipranks
Trending News
More News >
Rebus Holdings (RBSH)
OTHER OTC:RBSH
US Market
Advertisement

Rebus Holdings (RBSH) Price & Analysis

Compare
45 Followers

RBSH Stock Chart & Stats


RBSH FAQ

What was Rebus Holdings’s price range in the past 12 months?
Currently, no data Available
What is Rebus Holdings’s market cap?
Rebus Holdings’s market cap is $3.21K.
    When is Rebus Holdings’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Rebus Holdings’s earnings last quarter?
    Currently, no data Available
    Is Rebus Holdings overvalued?
    According to Wall Street analysts Rebus Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Rebus Holdings pay dividends?
      Rebus Holdings does not currently pay dividends.
      What is Rebus Holdings’s EPS estimate?
      Rebus Holdings’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Rebus Holdings have?
      Rebus Holdings has 32,132,908 shares outstanding.
        What happened to Rebus Holdings’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Rebus Holdings?
        Currently, no hedge funds are holding shares in RBSH

        Company Description

        Rebus Holdings

        Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.

        Rebus Holdings (RBSH) Earnings & Revenues

        Currently, no data available
        Please return soon. This page is being updated.
        Similar Stocks
        Company
        Price & Change
        Follow
        Nuwellis
        Salarius Pharmaceuticals
        Scinai Immunotherapeutics
        Oragenics
        SCWorx

        Ownership Overview

        <0.01%100.00%
        Insiders
        Mutual Funds
        <0.01% Other Institutional Investors
        100.00% Public Companies and
        Individual Investors

        Options Prices

        Currently, No data available
        ---
        Popular Stocks
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis